IL-17 in Severe Asthma. Where Do We Stand?
Top Cited Papers
- 15 November 2014
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 190 (10), 1094-1101
- https://doi.org/10.1164/rccm.201405-0859pp
Abstract
Asthma is a major chronic disease ranging from mild to severe refractory disease and is classified into various clinical phenotypes. Severe asthma is difficult to treat and frequently requires high doses of systemic steroids. In some cases, severe asthma even responds poorly to steroids. Several studies have suggested a central role of IL-17 (also called IL-17A) in severe asthma. Indeed, high levels of IL-17 are found in induced sputum and bronchial biopsies obtained from patients with severe asthma. The recent identification of a steroid-insensitive pathogenic Th17 pathway is therefore of major interest. In addition, IL-17A has been described in multiple aspects of asthma pathogenesis, including structural alterations of epithelial cells and smooth muscle contraction. In this perspective article, we frame the topic of IL-17A effects in severe asthma by reviewing updated information from human studies. We summarize and discuss the implications of IL-17 in the induction of neutrophilic airway inflammation, steroid insensitivity, the epithelial cell profile, and airway remodeling.Keywords
This publication has 89 references indexed in Scilit:
- Co-Culture of Human Bronchial Fibroblasts and CD4+ T Cells Increases Th17 Cytokine SignaturePLOS ONE, 2013
- Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodelingMucosal Immunology, 2012
- IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contractionNature Medicine, 2012
- Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunityJournal of Allergy and Clinical Immunology, 2011
- Management of severe asthma in childrenThe Lancet, 2010
- Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthmaNature Immunology, 2010
- Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytesJournal of Allergy and Clinical Immunology, 2010
- IL-17–producing T cells in lung immunity and inflammationJournal of Allergy and Clinical Immunology, 2009
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 SignalingImmunity, 2009
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2007